Search IPOs
Subscription Status · Jan 21 – Jan 23, 2026 · ₹128–135
KRM Ayurveda IPO subscribed 74.27 times — as of Jan 24, 2026
The KRM Ayurveda IPO subscription has recorded exceptional investor demand with an overall subscription of 74.27× as of Jan 24, 2026, indicating that investors applied for 74.27 times the number of shares on offer. All investor categories — institutional, HNI, and retail — have participated actively, making this one of the closely watched IPO openings.
As of January 24, 2026
| Category | Shares Offered | Shares Bid For | Times Subscribed | Applications |
|---|---|---|---|---|
|
QIB
Qualified Institutional Buyers
|
1,032,000 | 65,338,000 |
63.31×
|
1,032 |
|
NII
Non-Institutional Investors
|
780,000 | 105,585,000 |
135.37×
|
780 |
|
bNII
Bids above ₹10L
|
520,000 | 86,595,000 |
166.53×
|
520 |
|
sNII
Bids below ₹10L
|
260,000 | 18,990,000 |
73.04×
|
260 |
|
Retail
Retail Individual Investors
|
1,812,000 | 98,222,000 |
54.21×
|
1,812 |
|
Total
|
3,624,000 | 269,145,000 |
74.27×
|
4,404 |
How subscription built up across investor categories over time
Snapshot of each day's bidding activity
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 1,032,000 | 65,338,000 | 63.31× | 1,032 |
| NII | 780,000 | 105,585,000 | 135.37× | 780 |
| bNII | 520,000 | 86,595,000 | 166.53× | 520 |
| sNII | 260,000 | 18,990,000 | 73.04× | 260 |
| Retail | 1,812,000 | 98,222,000 | 54.21× | 1,812 |
| Total | 3,624,000 | 269,145,000 | 74.27× | 4,404 |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 1,032,000 | 65,338,000 | 63.31× | 58 |
| NII | 780,000 | 106,159,000 | 136.10× | 16,637 |
| bNII | 520,000 | 87,169,000 | 167.63× | 10,615 |
| sNII | 260,000 | 18,990,000 | 73.04× | 6,022 |
| Individual Investors | 6,668,000 | 98,222,000 | 14.73× | 49,111 |
| Total | 8,480,000 | 269,719,000 | 31.81× | 82,443 |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 1,032,000 | 3,000 | — | 1 |
| NII | 780,000 | 5,058,000 | 6.48× | 788 |
| bNII | 520,000 | 4,086,000 | 7.86× | 473 |
| sNII | 260,000 | 972,000 | 3.74× | 315 |
| Individual Investors | 6,668,000 | 8,440,000 | 1.27× | 4,220 |
| Total | 8,480,000 | 13,501,000 | 1.59× | 5,797 |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| NII | 780,000 | 1,294,000 | 1.66× | 180 |
| bNII | 520,000 | 1,002,000 | 1.93× | 88 |
| sNII | 260,000 | 292,000 | 1.12× | 92 |
| Individual Investors | 1,812,000 | 2,968,000 | 1.64× | 1,484 |
| Total | 2,592,000 | 4,262,000 | 1.64× | 1,844 |
As of January 24, 2026, the KRM Ayurveda IPO has been subscribed 74.27 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest. A total of 4,404 applications received across all categories.
The KRM Ayurveda IPO subscription window was open from January 21, 2026 to January 23, 2026. Investors could apply through their demat account or ASBA facility.
The KRM Ayurveda IPO has a price band of ₹128 to ₹135 per share, with a lot size of 1,000 shares. Minimum retail investment: ₹128,000 (lower band) or ₹135,000 (upper band).
The QIB category has been subscribed 63.31 times. QIBs were offered 1,032,000 shares. Strong QIB subscription indicates high institutional confidence.
Retail investors subscribed 54.21 times. Retail was offered 1,812,000 shares. High retail subscription reflects strong small-investor interest.
Overall NII: 135.37×. bNII (>₹10L): 166.53×, sNII (<₹10L): 73.04×. NII includes HNIs and corporate entities investing above ₹2 lakh.
Basis of allotment is on January 27, 2026. Check via the registrar's website — Skyline Financial Services Pvt.Ltd. using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.
KRM Ayurveda IPO is expected to list on January 29, 2026. Shares will list on NSE SME platform. Allotted shares are credited to your demat account 1 business day before listing.
A subscription multiple of 74.27× means investors have bid for 74.27 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares — allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.
Based on the current retail subscription of 54.21×, the estimated allotment probability for retail investors is Low. Lottery-based; ~1 lot if allotted. Retail allotment in oversubscribed IPOs is done by computerised lottery — each valid application has an equal probability regardless of the number of lots applied for.
You can apply for KRM Ayurveda IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Jan 21 to Jan 23, 2026.
The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest KRM Ayurveda IPO GMP data, check the IPO Rise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price — use it only as a sentiment signal alongside official subscription data.
The KRM Ayurveda IPO subscription tracks how many times each investor category has subscribed relative to their reserved quota. As of Jan 24, 2026, the overall subscription stands at 74.27× — Heavily Oversubscribed.
QIBs include domestic mutual funds, FIIs/FPIs, banks, insurance companies, and SEBI-registered venture capital funds. They are allocated up to 50% of the net offer (75% for SME IPOs). For KRM Ayurveda IPO, QIB subscription is at 63.31×. High QIB subscription signals strong institutional conviction and is considered a positive indicator for post-listing performance.
NIIs are high-net-worth individuals (HNIs) and corporate bodies applying for more than ₹2 lakh. SEBI further divides this into bNII (bids above ₹10 lakh) and sNII (bids between ₹2–10 lakh), each with a separate allotment bucket. For KRM Ayurveda IPO: bNII at 166.53×, sNII at 73.04×. Very high NII subscription (>50×) often signals leveraged HNI bidding, suggesting a strong listing expectation.
Retail investors apply for up to ₹2 lakh. They are reserved 35% of the net offer (in most mainboard IPOs). If oversubscribed, allotment is via computerised lottery — each applicant (regardless of lot count) has an equal probability. KRM Ayurveda IPO retail subscription: 54.21×. With 54.21× retail subscription, allotment is lottery-based.
Price band: ₹128–₹135 per share. Lot size: 1,000 shares. Minimum retail investment at upper band: ₹135,000. Applications must be in multiples of 1,000 shares.
Stock exchanges (BSE/NSE) publish subscription data multiple times a day during the subscription window. The figures shown here represent the latest available snapshot. "Shares Offered" is the quota reserved for each category; "Shares Bid For" is the total demand received; "Times Subscribed" is the ratio of demand to supply.
Subscription Opens Done
Jan 21, 2026Subscription Closes Done
Jan 23, 2026Basis of Allotment Done
Jan 27, 2026Listing on NSE Done
Jan 29, 2026Lottery-based; ~1 lot if allotted. Based on retail subscription of 54.21×.
Retail allotment in oversubscribed IPOs is done by computerised lottery — each valid application has equal odds regardless of lot size applied.
Share Subscription Card
Download a branded image to share on WhatsApp, Twitter, or Telegram
Higher subscription = lower allotment probability. Progress bars compare each category relative to the highest-subscribed category.